T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Becton Dickinson
BDX
|
+$3.36B |
| 2 |
UnitedHealth
UNH
|
+$2.85B |
| 3 |
Salesforce
CRM
|
+$2.23B |
| 4 |
Philip Morris
PM
|
+$1.3B |
| 5 |
Sherwin-Williams
SHW
|
+$1.23B |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$3.71B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.75B |
| 3 |
GE Aerospace
GE
|
+$1.88B |
| 4 |
HCA Healthcare
HCA
|
+$1.7B |
| 5 |
American International
AIG
|
+$1.48B |
Sector Composition
| 1 | Technology | 26.74% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.06% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Stoke Therapeutics
STOK
$1.29B
| $5.51M | ﹤0.01% |
416,721
-7,142
| -2% | -$94.3K |
|
1402
iShares 1-3 Year Treasury Bond ETF
SHY
$24.5B
| $5.46M | ﹤0.01% |
65,885
+21,200
| +47% | +$1.76M |
|
1403
Regenxbio
RGNX
$465M
| $5.43M | ﹤0.01% |
219,906
-30,211
| -12% | -$746K |
|
1404
American Financial Group
AFG
$11.7B
| $5.43M | ﹤0.01% |
39,081
+152
| +0.4% | +$21.1K |
|
1405
Teva Pharmaceuticals
TEVA
$22.9B
| $5.41M | ﹤0.01% |
718,904
+68,189
| +10% | +$513K |
|
1406
Sunrun
RUN
$3.71B
| $5.35M | ﹤0.01% |
228,816
-16,189
| -7% | -$378K |
|
1407
DigitalOcean
DOCN
$3.25B
| $5.23M | ﹤0.01% |
126,489
+26,556
| +27% | +$1.1M |
|
1408
SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$8.12B
| $5.13M | ﹤0.01% |
+172,667
| New | +$5.13M |
|
|
CCMP
1409
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $5.13M | ﹤0.01% |
29,402
+790
| +3% | +$138K |
|
1410
Kodiak Sciences
KOD
$489M
| $5.02M | ﹤0.01% |
656,418
-27,730
| -4% | -$212K |
|
1411
TIM SA
TIMB
$10.3B
| $4.98M | ﹤0.01% |
410,000
| – | – |
|
1412
Design Therapeutics
DSGN
$343M
| $4.94M | ﹤0.01% |
353,109
-220,903
| -38% | -$3.09M |
|
1413
Annaly Capital Management
NLY
$14.1B
| $4.92M | ﹤0.01% |
207,958
+11,219
| +6% | +$265K |
|
1414
Voyager Therapeutics
VYGR
$232M
| $4.89M | ﹤0.01% |
827,950
+782,850
| +1,736% | +$4.63M |
|
1415
Liberty Global Class C
LBTYK
$4.07B
| $4.88M | ﹤0.01% |
220,765
-6,800
| -3% | -$150K |
|
1416
Crown Holdings
CCK
$11.2B
| $4.83M | ﹤0.01% |
52,392
-11,533
| -18% | -$1.06M |
|
1417
Bloom Energy
BE
$15.7B
| $4.79M | ﹤0.01% |
290,365
-96,201
| -25% | -$1.59M |
|
1418
Toronto Dominion Bank
TD
$131B
| $4.72M | ﹤0.01% |
72,166
-113
| -0.2% | -$7.39K |
|
|
LBPH
1419
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $4.67M | ﹤0.01% |
1,511,739
-500
| -0% | -$1.55K |
|
1420
Lucid Motors
LCID
$5.92B
| $4.63M | ﹤0.01% |
26,967
+3,829
| +17% | +$657K |
|
|
LIAN
1421
DELISTED
LianBio American Depositary Shares
LIAN
| $4.59M | ﹤0.01% |
2,126,878
-115,511
| -5% | -$250K |
|
1422
Ryder
R
$7.65B
| $4.56M | ﹤0.01% |
64,226
-6,425
| -9% | -$457K |
|
1423
Vir Biotechnology
VIR
$695M
| $4.5M | ﹤0.01% |
176,539
-273,824
| -61% | -$6.97M |
|
1424
Lamar Advertising Co
LAMR
$12.9B
| $4.48M | ﹤0.01% |
50,911
+4,870
| +11% | +$428K |
|
1425
MoonLake Immunotherapeutics
MLTX
$3.34B
| $4.44M | ﹤0.01% |
870,524
+304,333
| +54% | +$1.55M |
|